Pharmacokinetic and bioequivalence study of apremilast tablets in healthy Chinese subjects under fasting and fed conditions
Int. Journal of Clinical Pharmacology and Therapeutics · 01.09.2026 · 64 (09) · 487-497
DOI: 10.5414/cp204869 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.09.2026. Verfasst von Pan Lu und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Thalidomide, Fasting, Phosphodiesterase 4 Inhibitors, Anti-Inflammatory Agents, Non-Steroidal.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Lu, P., Yao, F., Wang, J., He, Y., Liang, J., Zhai, X., & Liu, G. (2026). Pharmacokinetic and bioequivalence study of apremilast tablets in healthy Chinese subjects under fasting and fed conditions. Int. Journal of Clinical Pharmacology and Therapeutics, 64(09), 487-497. https://doi.org/10.5414/cp204869
Vancouver
Lu P, Yao F, Wang J, He Y, Liang J, Zhai X, et al. Pharmacokinetic and bioequivalence study of apremilast tablets in healthy Chinese subjects under fasting and fed conditions. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(09):487-497. doi:10.5414/cp204869
BibTeX
@article{Lu2026,
author = {Lu, Pan and Yao, Fang and Wang, Jie and He, Yingxia and Liang, Jun and Zhai, Xuejia and Liu, Guan},
title = {Pharmacokinetic and bioequivalence study of apremilast tablets in healthy Chinese subjects under fasting and fed conditions},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
volume = {64},
number = {09},
pages = {487--497},
doi = {10.5414/cp204869}
}
EUVIMED